Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ligand Pharmaceuticals (LGND) Return on Assets (2016 - 2025)

Ligand Pharmaceuticals' Return on Assets history spans 13 years, with the latest figure at 0.04% for Q3 2025.

  • For Q3 2025, Return on Assets changed N/A year-over-year to 0.04%; the TTM value through Sep 2025 reached 0.04%, changed N/A, while the annual FY2024 figure was 0.0%, 0.0% changed from the prior year.
  • Return on Assets for Q3 2025 was 0.04% at Ligand Pharmaceuticals, up from 0.07% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.04% in Q3 2025 and bottomed at 0.08% in Q1 2025.
  • The 5-year median for Return on Assets is 0.02% (2021), against an average of 0.02%.
  • The largest annual shift saw Return on Assets rose 7bps in 2021 before it dropped -3bps in 2022.
  • A 5-year view of Return on Assets shows it stood at 0.01% in 2021, then tumbled by -108bps to 0.03% in 2022, then soared by 93bps to 0.0% in 2023, then tumbled by -1432bps to 0.03% in 2024, then skyrocketed by 222bps to 0.04% in 2025.
  • Per Business Quant, the three most recent readings for LGND's Return on Assets are 0.04% (Q3 2025), 0.07% (Q2 2025), and 0.08% (Q1 2025).